Table 3.
Comparison of outcomes for patients who successfully suppressed viremia to <1000cp/ml with patients who were unable to suppress viral replication while on treatment
| Suppressed (n = 41) | Never suppressed (n = 48) | |
|---|---|---|
| Gender: |
|
|
| Male |
23 |
30 |
| At initiation: |
|
|
| Age, years, median (IQR) |
6.9 (4.4-9.8) |
7.1 (3.2-9.6) |
| Viral load, log10 cp/ml, median (IQR) |
3.8 (3.4-4.7) |
4.2 (3.7-4.7) |
| CD4, cells/μl, median (IQR) |
290 (136–563) |
281 (89–560) |
| Regimen |
|
|
| 3TC-D4T-EFV |
33 |
31 |
| 3TC-D4T-LPV/r |
6 |
6 |
| 3TC-ABC-EFV |
1 |
7 |
| 3TC-ABC-LPV/r |
0 |
4 |
| 3TC-AZT-EFV |
1 |
0 |
| At genotyping: |
|
|
| Age, years, median (IQR)* | 11.1 (8.5-13.1) | 9.8 (5.6-12.3) |
Key: *Statistical significance (T-test, P<0.05).